Your browser doesn't support javascript.
loading
Chromatin complex dependencies reveal targeting opportunities in leukemia.
Najm, Fadi J; DeWeirdt, Peter; Moore, Molly M; Bevill, Samantha M; El Farran, Chadi A; Macias, Kevin A; Hegde, Mudra; Waterbury, Amanda L; Liau, Brian B; van Galen, Peter; Doench, John G; Bernstein, Bradley E.
Afiliação
  • Najm FJ; Gene Regulation Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • DeWeirdt P; Genetic Perturbation Platform, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Moore MM; Gene Regulation Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Bevill SM; Gene Regulation Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • El Farran CA; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Macias KA; Departments of Cell Biology and Pathology, Harvard Medical School, Boston, MA, USA.
  • Hegde M; Gene Regulation Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Waterbury AL; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Liau BB; Departments of Cell Biology and Pathology, Harvard Medical School, Boston, MA, USA.
  • van Galen P; Gene Regulation Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Doench JG; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Bernstein BE; Departments of Cell Biology and Pathology, Harvard Medical School, Boston, MA, USA.
Nat Commun ; 14(1): 448, 2023 01 27.
Article em En | MEDLINE | ID: mdl-36707513
ABSTRACT
Chromatin regulators are frequently mutated in human cancer and are attractive drug targets. They include diverse proteins that share functional domains and assemble into related multi-subunit complexes. To investigate functional relationships among these regulators, here we apply combinatorial CRISPR knockouts (KOs) to test over 35,000 gene-gene pairings in leukemia cells, using a library of over 300,000 constructs. Top pairs that demonstrate either compensatory non-lethal interactions or synergistic lethality enrich for paralogs and targets that occupy the same protein complex. The screen highlights protein complex dependencies not apparent in single KO screens, for example MCM histone exchange, the nucleosome remodeling and deacetylase (NuRD) complex, and HBO1 (KAT7) complex. We explore two approaches to NuRD complex inactivation. Paralog and non-paralog combinations of the KAT7 complex emerge as synergistic lethal and specifically nominate the ING5 PHD domain as a potential therapeutic target when paired with other KAT7 complex member losses. These findings highlight the power of combinatorial screening to provide mechanistic insight and identify therapeutic targets within redundant networks.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromatina / Leucemia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Cromatina / Leucemia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos